Last reviewed · How we verify
NCT07123181
Oregano and Basil Leaves and Coronary Artery Disease
NA trial testing Control (Standard treatment) in Acute Coronary Syndromes in 70 participants. Currently enrolling.
17 March 2026
Quick facts
| Lead sponsor | Shahid Beheshti University of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 70 |
| Start date | 1 September 2025 |
| Primary completion | 17 March 2026 |
| Estimated completion | 2 June 2026 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Control (Standard treatment) — full drug profile →
- Higher polyphenol intake by consumption of oregano and basil
Conditions studied
- Acute Coronary Syndromes — all drugs for Acute Coronary Syndromes →
- Unstable Angina (UA) — all drugs for Unstable Angina (UA) →
Sponsor
Shahid Beheshti University of Medical Sciences
Who can join
Adults 30 to 75, any sex, with Acute Coronary Syndromes or Unstable Angina (UA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07123181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Control (Standard treatment)
Trials testing the same drug.
- NCT07437014 — The Effect of Abdomınal Massage and Warm Water Consumptıon on Postoperatıve Constıpatıon Development and Qualıty of Reco · NA · not yet recruiting
- NCT07160959 — Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions · NA · not yet recruiting
- NCT06838624 — RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06807970 — Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist · EARLY_PHASE1 · not yet recruiting
- NCT07046091 — Effects of a 20-Minute Mindfulness-Based Breathing Exercise on Dyspnea, Fatigue, and Sleep Quality in Patients With Hear · NA · not yet recruiting
Other recruiting trials for Acute Coronary Syndromes
Currently open trials in the same condition.
- NCT06927739 — Focused Orticumab Research for Treating Inflammation in Coronary Arteries · Phase 2 · recruiting
- NCT06845826 — Point-of-Care Troponin Testing in the Emergency Department · NA · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting
- NCT06813339 — Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients · EARLY_PHASE1 · recruiting
Other Shahid Beheshti University of Medical Sciences trials
Trials by the same sponsor.
- NCT07005687 — Using MSCs for Chronic Active Antibody Mediated Rejection · NA · not yet recruiting
- NCT07435558 — Homogeneous vs. Heterogeneous Learning Style Grouping in Problem-Based Learning Among Nurses · NA · not yet recruiting
- NCT07408492 — Impact of AI-Based Research Training on Nursing Students · NA · not yet recruiting
- NCT07176663 — Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure · NA · not yet recruiting
- NCT07291622 — Synchrony-Optimized Non-Invasive Ventilation Education Program and ICU Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07123181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shahid Beheshti University of Medical Sciences
- Last refreshed: 20 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing